Please sign in to follow a disease.

Xeroderma pigmentosum group D

MONDO:0010212

Any xeroderma pigmentosum in which the cause of the disease is a mutation in the ERCC2 gene.

Also known as: ERCC2 xeroderma pigmentosum, XP-D, XP4, XPD, XPDC, xeroderma pigmentosum caused by mutation in ERCC2, xeroderma pigmentosum group D, xeroderma pigmentosum group type D

3 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Skin disorder (132) Inborn errors of metabolism (45) Syndromic disease (25) Human disease (14) DNA repair disease (13) Hereditary skin disorder (6) Xeroderma pigmentosum (4)

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug combo shows promise for Hard-to-Treat cancers

Disease control Completed

This early-stage study tested two drugs, cabozantinib and pamiparib, together in 44 people with advanced solid tumors that had stopped responding to standard treatments. The goal was to find the safest dose and understand side effects. The drugs work by blocking certain enzymes t…

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

Xeroderma pigmentosum group D

Broader categories

New drug combo shows promise for Hard-to-Treat cancers